Christopher Haig, Founder & CEO, Efemoral Medical
Mr. Haig has a proven track record with more than 25 years of experience in the field of medical technology, primarily in the domain of cardiovascular devices, at large, multi-national corporations as well as growth-phase companies with novel technologies. At Guidant Corporation and Abbott Vascular, he held numerous positions of increasing responsibility in marketing, sales and business development functions. Mr. Haig also has extensive start-up experience in senior management positions at Calypso Medical (acquired by Varian Medical Systems) and QT Vascular (S$55 million IPO in 2014), where he built the company’s commercial infrastructure and successfully launched several innovative devices. He holds a B.A. degree from UC Berkeley and an M.B.A. degree from the Kenan Flagler School of Management at the University of North Carolina, Chapel Hill.